Dr. Reva Schneider
Claim this profileMary Crowley Cancer Research
Studies Tumors
Studies Solid Tumors
9 reported clinical trials
11 drugs studied
Area of expertise
1Tumors
Stage IV
microsatellite-instability
PD 1/PD-L1
2Solid Tumors
Stage IV
microsatellite-instability
PD 1/PD-L1
Affiliated Hospitals
Clinical Trials Reva Schneider is currently running
ABSK061
for Solid Tumors
This is an open-label phase 1 study with expansion. The study will start with a dose escalation of single-agent ABSK061 administered in repeated 28-day cycles in patients with advanced solid tumors to evaluate safety and tolerability. The expansion part will investigate oral ABSK061 at the recommended dose for expansion (RDE) to further evaluate safety and tolerability among selected tumor types. Preliminary antitumor activity will also be assessed.
Recruiting1 award Phase 1
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
More about Reva Schneider
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Reva Schneider has experience with
- PD-1 Inhibitor
- ELU001
- CAB-AXL-ADC
- IMP7068
- STI-6643
- Pembrolizumab
Breakdown of trials Reva Schneider has run
Tumors
Solid Tumors
Non-Small Cell Lung Cancer
Ovarian Tumors
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Reva Schneider specialize in?
Reva Schneider focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are microsatellite-instability.
Is Reva Schneider currently recruiting for clinical trials?
Yes, Reva Schneider is currently recruiting for 6 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Reva Schneider has studied deeply?
Yes, Reva Schneider has studied treatments such as PD-1 inhibitor, ELU001, CAB-AXL-ADC.
What is the best way to schedule an appointment with Reva Schneider?
Apply for one of the trials that Reva Schneider is conducting.
What is the office address of Reva Schneider?
The office of Reva Schneider is located at: Mary Crowley Cancer Research, Dallas, Texas 75230 United States. This is the address for their practice at the Mary Crowley Cancer Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.